Quality clinical research remains a high priority during the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) coronavirus disease (COVID‐19) pandemic response, however, the logistical barriers of conducting research across institutions with differing departmental policy responses and varying resources is a documented problem.